Spots Global Cancer Trial Database for malignant tumor
Every month we try and update this database with for malignant tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Malignant Tumor | NCT02632370 | Malignant Gliom... | Gliolan® Fluorescence-Gu... | 18 Years - 80 Years | Icahn School of Medicine at Mount Sinai | |
| Evaluation of Fibrin Structure Marker in Cancer Patients Treated and Not Treated With LMWH | NCT02552381 | Malignant Tumor | Fibrin Structur... | 18 Years - | Diagnostica Stago R&D | |
| Effect of Intraoperative Dexmedetomidine on Development of Acute Kidney Injury | NCT02641938 | Malignant Tumor | Dexmedetomidine Normal Saline | 20 Years - | Gangnam Severance Hospital | |
| MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers | NCT05986981 | Solid Tumor, Ad... | Vaccine | 18 Years - 75 Years | Peking Union Medical College Hospital | |
| A Real-world Study of the Efficacy and Safety of ICIs as First-line Therapy for Advanced Malignancies | NCT05862259 | Malignant Tumor Immunotherapy Artificial Inte... | 18 Years - 75 Years | Xinqiao Hospital of Chongqing | ||
| Clinical Research of ROBO1 Specific BiCAR-NK/T Cells on Patients With Malignant Tumor | NCT03931720 | Malignant Tumor | BiCAR-NK/T cell... | 18 Years - 75 Years | Asclepius Technology Company Group (Suzhou) Co., Ltd. | |
| Prospective Screening Programme for Malignant Tumors | NCT04230200 | Hematologic Tes... Malignant Tumor | 18 Years - 75 Years | Sun Yat-sen University | ||
| HGS-ETR2 to Treat Children With Solid Tumors | NCT00428272 | Ewing's Sarcoma Osteosarcoma Neuroblastoma Rhabdomyosarcom... | Lexatumumab alo... Lexatumumab in ... Interferon gamm... Gamma 1b potent... | 1 Year - 30 Years | National Institutes of Health Clinical Center (CC) | |
| Assessment of Intraoperative Probe-based Confocal Laser Endomicroscopy in Digestive and Endocrine Surgery: a Pilot Study | NCT02552004 | All Surgical Co... Malignant Tumor Inflammatory Di... Benign Tumor | pCLE IV fluorescein ... | 18 Years - | IHU Strasbourg | |
| A Study of ES101 (PD-L1x4-1BB Bispecific Antibody) in Patients With Advanced Solid Tumors | NCT04009460 | Solid Tumors Neoplasms Malignant Tumor | ES101 | 18 Years - | Elpiscience Biopharma, Ltd. | |
| Establishment of Tongue Image Database and Machine Learning Model for Malignant Tumors Diagnosis | NCT04793672 | Malignant Tumor | Tongue images, ... | 18 Years - 80 Years | Zhejiang Cancer Hospital | |
| Establishment of Tongue Image Database and Machine Learning Model for Malignant Tumors Diagnosis | NCT04793672 | Malignant Tumor | Tongue images, ... | 18 Years - 80 Years | Zhejiang Cancer Hospital | |
| Long-term Follow-up of Anxiety and Depression in Patients With Malignant Tumors | NCT05596344 | Malignant Tumor Anxiety Depression | Hospital Anxiet... | - | Henan Cancer Hospital | |
| Drugs for the Treatment of Multiple Sclerosis and Risk of Cancer: a Pharmacovigilance Analysis in Vigibase | NCT04237337 | Multiple Sclero... Malignant Tumor | Exposure to MS ... | - | University Hospital, Caen | |
| Effect of Intraoperative Dexmedetomidine on Development of Acute Kidney Injury | NCT02641938 | Malignant Tumor | Dexmedetomidine Normal Saline | 20 Years - | Gangnam Severance Hospital | |
| A Study of ES102 (OX40 Agonist) in Patients With Advanced Solid Tumors | NCT04730843 | Solid Tumors Neoplasms Malignant Tumor | ES102 | 18 Years - | Elpiscience Biopharma, Ltd. | |
| Stimulation of Acupuncture Points by Athermic Laser Therapy for the Prevention of Chemotherapy Induced Nausea and Vomiting in Children | NCT03354741 | Children Chemotherapy-in... Malignant Tumor | laser therapy | 2 Years - 20 Years | Centre Hospitalier Universitaire de Nice | |
| CAR-T for r/r Malignant Tumors in Children | NCT04691349 | CAR-T Child, Only Malignant Tumor | CAR-T | 3 Years - 18 Years | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | |
| A Study of Diffusing Alpha Radiation Therapy for Target Treatments of Malignant Tumors | NCT05781555 | Malignant Tumor | Experimental: D... | 18 Years - | Alpha Tau Medical LTD. | |
| Study of Gene Expression Profiling and Immunological Mechanism Affects the Response of Immunotherapy | NCT01884168 | Malignant Tumor | Dc-CIK immunoth... | 18 Years - 80 Years | Capital Medical University | |
| Assessment of Intraoperative Probe-based Confocal Laser Endomicroscopy in Digestive and Endocrine Surgery: a Pilot Study | NCT02552004 | All Surgical Co... Malignant Tumor Inflammatory Di... Benign Tumor | pCLE IV fluorescein ... | 18 Years - | IHU Strasbourg | |
| Surgical Approach for Retrorectal Tumors Cohort | NCT04757103 | Malignant Tumor | Resection of th... | 18 Years - 99 Years | University Hospital, Montpellier | |
| Pirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of CIP | NCT05280873 | Pneumonitis Malignant Tumor | Pirfenidone, me... Methylprednisol... | 18 Years - 75 Years | Guangzhou Institute of Respiratory Disease | |
| Clinical Study of Therapeutic Immunological Agent for EBV-positive Advanced Malignant Tumors | NCT05707910 | Malignant Tumor | EBV immunologic... | 18 Years - 70 Years | West China Hospital | |
| Evaluation of Fibrin Structure Marker in Cancer Patients Treated and Not Treated With LMWH | NCT02552381 | Malignant Tumor | Fibrin Structur... | 18 Years - | Diagnostica Stago R&D | |
| Application of LARS Ligament in Bone Prosthesis Replacement | NCT05616182 | Malignant Tumor | LARS ligament a... | - | Henan Cancer Hospital | |
| A Study of Diffusing Alpha Radiation Therapy for Target Treatments of Malignant Tumors | NCT05781555 | Malignant Tumor | Experimental: D... | 18 Years - | Alpha Tau Medical LTD. | |
| Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults | NCT04952766 | Kidney Transpla... Myeloma Cancer Hematologic Mal... Multiple Sclero... Hypergammaglobu... Malignant Tumor Hiv Diabetes Type 2 | Biological samp... | 18 Years - | Centre Hospitalier Régional d'Orléans | |
| Imaging and Plan Workflow in a Novel Low-Field Magnetic Resonance Imaging (MRI) Radiotherapy Device | NCT02331381 | Cancer Malignant Tumor | Magnetic resona... | 18 Years - | Washington University School of Medicine | |
| Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors | NCT04145622 | Advanced Solid ... Malignant Solid... | Ifinatamab deru... | 18 Years - | Daiichi Sankyo | |
| Cancer Genome Analysis | NCT01458704 | Malignant Tumor | next generation... | 18 Years - | Seoul National University Hospital | |
| Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer | NCT05168566 | Non-small Cell ... | Sutetinib Malea... | 18 Years - | Teligene US | |
| Effect of Intraoperative Dexmedetomidine on Development of Acute Kidney Injury | NCT02641938 | Malignant Tumor | Dexmedetomidine Normal Saline | 20 Years - | Gangnam Severance Hospital | |
| Cancer Genome Analysis | NCT01458704 | Malignant Tumor | next generation... | 18 Years - | Seoul National University Hospital | |
| Sodium Selenite as a Cytotoxic Agent in Advanced Carcinoma | NCT01959438 | Malignant Tumor Treatment Resis... Tumor Progressi... | Sodium selenite... Sodium selenite | 18 Years - | Karolinska University Hospital | |
| Study To Assess Long Term Safety Of Pazopanib | NCT00387205 | Carcinoma, Rena... | Pazopanib | 18 Years - | Novartis | |
| Long-term Follow-up of Anxiety and Depression in Patients With Malignant Tumors | NCT05596344 | Malignant Tumor Anxiety Depression | Hospital Anxiet... | - | Henan Cancer Hospital | |
| Evaluation of Fibrin Structure Marker in Cancer Patients Treated and Not Treated With LMWH | NCT02552381 | Malignant Tumor | Fibrin Structur... | 18 Years - | Diagnostica Stago R&D | |
| Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors | NCT05714748 | Malignant Tumor... | EBV mRNA vaccin... | 18 Years - 70 Years | West China Hospital | |
| Sodium Selenite as a Cytotoxic Agent in Advanced Carcinoma | NCT01959438 | Malignant Tumor Treatment Resis... Tumor Progressi... | Sodium selenite... Sodium selenite | 18 Years - | Karolinska University Hospital | |
| Tabectedin to Treat Children and Adolescents With Cancer | NCT01453283 | Solid Tumors | Trabectedin (ec... | 4 Years - 16 Years | National Institutes of Health Clinical Center (CC) | |
| A Study of ES102 (OX40 Agonist) in Combination With JS001 in Patients With Advanced Solid Tumors | NCT04991506 | Solid Tumor Neoplasms Malignant Tumor | ES102 JS001 | 18 Years - | Elpiscience Biopharma, Ltd. | |
| Imaging and Plan Workflow in a Novel Low-Field Magnetic Resonance Imaging (MRI) Radiotherapy Device | NCT02331381 | Cancer Malignant Tumor | Magnetic resona... | 18 Years - | Washington University School of Medicine | |
| Serum miR-122 as a Real-time Detection Biomarker of Drug-induced Liver Injury by Chemotherapy | NCT03039062 | Chemotherapeuti... Malignant Tumor Liver Injury | 18 Years - 70 Years | ChineseAMS | ||
| Effect of Omeprazole on Pharmacokinetics of SHR2554 in Healthy Subjects | NCT06093945 | Malignant Tumor | SHR2554 tablet ... Omeprazole tabl... | 18 Years - 45 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| Establishment of Tongue Image Database and Machine Learning Model for Malignant Tumors Diagnosis | NCT04793672 | Malignant Tumor | Tongue images, ... | 18 Years - 80 Years | Zhejiang Cancer Hospital | |
| XCHT for Irinotecan-Induced Gut Toxicities (Run-in Study) | NCT04926545 | Malignant Tumor Diarrhea | Xiao Chai Hu Ta... Raloxifene FOLFIRI regimen | 18 Years - 75 Years | Guangzhou University of Traditional Chinese Medicine | |
| Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors | NCT04145622 | Advanced Solid ... Malignant Solid... | Ifinatamab deru... | 18 Years - | Daiichi Sankyo | |
| ONO-7436 Phase II Study in Japan | NCT00212602 | Malignant Tumor | ONO-7436 | 20 Years - | Ono Pharmaceutical Co. Ltd | |
| Establishment of Tongue Image Database and Machine Learning Model for Malignant Tumors Diagnosis | NCT04793672 | Malignant Tumor | Tongue images, ... | 18 Years - 80 Years | Zhejiang Cancer Hospital | |
| Study Evaluating MST-997 in Advanced Malignant Solid Tumors | NCT00277836 | Neoplasms | MST-997 | 18 Years - | Wyeth is now a wholly owned subsidiary of Pfizer | |
| Intervention, Prognosis and Mechanism of Covid-19 Infection in Patients With Underlying Diseases | NCT05965843 | Chronic Liver D... Malignant Tumor Autoimmune Dise... Healthy | underling disea... | 18 Years - 100 Years | The Second Affiliated Hospital of Chongqing Medical University | |
| Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) | NCT05103358 | Tumor Tumor, Solid Metastasis Metastatic Canc... Cancer Cancer Metastat... Tumors Neoplasms Neoplasm Metast... Solid Tumor Advanced Solid ... Advanced Cancer Malignant Solid... Malignant Solid... Malignant Neopl... Malignant Tumor TSC TSC1 TSC2 Metastatic Soli... Metastatic Neop... | nab-sirolimus | 12 Years - | Aadi Bioscience, Inc. | |
| Pharmacokinetic Test of High-fat Diet After Oral Administration of SHR2554 in Healthy Subjects | NCT05592262 | Malignant Tumor | SHR2554 SHR2554 | 18 Years - 45 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Malignant Tumor | NCT02632370 | Malignant Gliom... | Gliolan® Fluorescence-Gu... | 18 Years - 80 Years | Icahn School of Medicine at Mount Sinai | |
| Efficacy of Partial Covered Double Bare Metal Stent Compared to Uncovered Double Bare Metal Stent in Malignant Biliary Obstruction | NCT02937246 | Malignant Tumor | SEMS(self-expan... Stenting by ERC... | 20 Years - | Yonsei University | |
| Surgical Approach for Retrorectal Tumors Cohort | NCT04757103 | Malignant Tumor | Resection of th... | 18 Years - 99 Years | University Hospital, Montpellier | |
| Application of Douyin in Patients With Bone and Soft Tissue Malignant Tumors During Perichemotherapy | NCT05598827 | Malignant Tumor Chemotherapy | Tik Tok | 10 Years - 70 Years | Henan Cancer Hospital | |
| Pharmacokinetic Test of High-fat Diet After Oral Administration of SHR2554 in Healthy Subjects | NCT05592262 | Malignant Tumor | SHR2554 SHR2554 | 18 Years - 45 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| Epidural Anesthesia-analgesia and Long-term Outcome | NCT03012945 | Elderly Malignant Tumor Surgical Resect... Epidural Anesth... Long-term Outco... | Combined epidur... General anesthe... | 60 Years - 90 Years | Peking University First Hospital | |
| Clinical Research of ROBO1 Specific BiCAR-NK/T Cells on Patients With Malignant Tumor | NCT03931720 | Malignant Tumor | BiCAR-NK/T cell... | 18 Years - 75 Years | Asclepius Technology Company Group (Suzhou) Co., Ltd. | |
| Study Evaluating MST-997 in Advanced Malignant Solid Tumors | NCT00277836 | Neoplasms | MST-997 | 18 Years - | Wyeth is now a wholly owned subsidiary of Pfizer | |
| Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) | NCT05103358 | Tumor Tumor, Solid Metastasis Metastatic Canc... Cancer Cancer Metastat... Tumors Neoplasms Neoplasm Metast... Solid Tumor Advanced Solid ... Advanced Cancer Malignant Solid... Malignant Solid... Malignant Neopl... Malignant Tumor TSC TSC1 TSC2 Metastatic Soli... Metastatic Neop... | nab-sirolimus | 12 Years - | Aadi Bioscience, Inc. | |
| A Multicenter "Ablate and Resect" Study of Novilase® Interstitial Laser Therapy for the Ablation of Small Breast Cancers | NCT01478438 | Malignant Tumor | Novilase Inters... | 18 Years - 80 Years | Novian Health Inc. | |
| Effect of Fluconazole on Pharmacokinetics of SHR2554 in Healthy Subjects | NCT05661591 | Malignant Tumor | SHR2554 Tablets Fluconazole Cap... | 18 Years - 45 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| A Study of ES102 (OX40 Agonist) in Combination With JS001 in Patients With Advanced Solid Tumors | NCT04991506 | Solid Tumor Neoplasms Malignant Tumor | ES102 JS001 | 18 Years - | Elpiscience Biopharma, Ltd. | |
| Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors | NCT05714748 | Malignant Tumor... | EBV mRNA vaccin... | 18 Years - 70 Years | West China Hospital | |
| Study To Assess Long Term Safety Of Pazopanib | NCT00387205 | Carcinoma, Rena... | Pazopanib | 18 Years - | Novartis | |
| A Multicenter "Ablate and Resect" Study of Novilase® Interstitial Laser Therapy for the Ablation of Small Breast Cancers | NCT01478438 | Malignant Tumor | Novilase Inters... | 18 Years - 80 Years | Novian Health Inc. | |
| Assessment of Intraoperative Probe-based Confocal Laser Endomicroscopy in Digestive and Endocrine Surgery: a Pilot Study | NCT02552004 | All Surgical Co... Malignant Tumor Inflammatory Di... Benign Tumor | pCLE IV fluorescein ... | 18 Years - | IHU Strasbourg | |
| Treatment of Malignant Tumors With Antigen Peptide-specific DC-CTL Cells and Decitabine | NCT04672473 | Malignant Tumor | DC-CTL | 18 Years - 70 Years | Shenzhen University General Hospital | |
| Intervention, Prognosis and Mechanism of Covid-19 Infection in Patients With Underlying Diseases | NCT05965843 | Chronic Liver D... Malignant Tumor Autoimmune Dise... Healthy | underling disea... | 18 Years - 100 Years | The Second Affiliated Hospital of Chongqing Medical University | |
| A Real-world Study of the Efficacy and Safety of ICIs as First-line Therapy for Advanced Malignancies | NCT05862259 | Malignant Tumor Immunotherapy Artificial Inte... | 18 Years - 75 Years | Xinqiao Hospital of Chongqing | ||
| MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers | NCT05986981 | Solid Tumor, Ad... | Vaccine | 18 Years - 75 Years | Peking Union Medical College Hospital | |
| Gene Expression Profiling of Malignant Tumor Predict the Therapeutic Response of DC-CIK Immunotherapy | NCT01906632 | Malignant Tumor | DC-CIK Immunoth... | 18 Years - 80 Years | Capital Medical University | |
| CAR-T for r/r Malignant Tumors in Children | NCT04691349 | CAR-T Child, Only Malignant Tumor | CAR-T | 3 Years - 18 Years | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | |
| A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors | NCT04686682 | NSCLC SCLC CRPC ESCC Ovarian Carcino... AML MF Malignant Tumor | JAB-8263 JAB-8263 | 18 Years - | Jacobio Pharmaceuticals Co., Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
